Multiple system atrophy (MSA) is a neurodegenerative disorder with limited treatment options. However, recent research has yielded potential discoveries into new therapeutic approaches. Current focus centers on addressing the underlying pathophysiology of MSA. One approach under investigation involves pharmacological interventions to regulate the